Tempus AI, based in Chicago, Illinois, went public on June 14, 2024, providing next-generation diagnostics through genomics and AI applications aimed at personalizing medicine. Its primary product, Next, uses machine learning to enhance oncology and cardiology care.
Eric P Lefkofsky sold 562,345 shares of TEM on 5 March at $52.73 per share, worth a total of $29.7M. They now own 26,321,502 TEM shares, or a 6% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
